跳到正文
原文
Medical Xpress·· 23 天前AI 评分60

Cell 研究:亨廷顿病 HTT 重复扩增机制在新皮质同样存在

Biological mechanism underlying Huntington's disease may be more widespread in the brain than previously thought

AI 导读

Broad Institute、哈佛医学院与 McLean Hospital 等团队在 Cell 发表研究,在 11 例亨廷顿病患者的新皮质样本中发现与纹状体类似的 HTT 基因 CAG 重复扩增机制。

正文
Biological mechanism underlying Huntington's disease may be more widespread in the brain than previously thought
A new study revealed that aggregations of the huntingtin protein (pink) occur within nuclei (blue) of cells with highly expanded DNA repeats in both the striatum and neocortex of individuals with Huntington's disease. Credit: McCarroll lab

In 2025, a team of scientists revealed some unexpected findings about how the inherited DNA repeat associated with Huntington's disease causes the illness—by slowly expanding throughout a person's life, then becoming toxic after enlarging to several times its original length. The findings were in a specific brain region, the striatum, but it wasn't clear if the same process was directly causing the harm in other parts of the brain affected by the disease.

Now, the research team, led by scientists at the Broad Institute, Harvard Medical School and McLean Hospital, has found that the same mechanism is indeed at play in another brain region damaged in Huntington's—the neocortex. Appearing online in Cell, the findings suggest that recently initiated efforts to develop medicines targeting this mechanism could protect multiple brain areas.

"These new results suggest that such medicines, if and when they're successfully developed, might be able to address not just one of the pathologies in the disease, but the two big ones," said Steve McCarroll, a geneticist, neuroscientist and co-senior author of the study.

Repeat discoveries

Scientists have known for decades that people who inherit a version of the huntingtin (HTT) gene in which a three-letter stretch of DNA ("CAG") is repeated 40 or more times are at high risk of developing Huntington's disease, a fatal neurodegenerative disorder. The 2025 study upended the field. It found that in the striatum, the brain region most damaged in the disease, the inherited HTT mutation becomes toxic only after accumulating 150 or more of the three-letter repeats.

In the new study, the researchers examined the HTT repeats and expression of other genes in more than 125,000 cells from neocortex samples from 11 people who had Huntington's disease. Just as they saw in striatal cells, cortical cell changes began after a cell's HTT gene expanded beyond a threshold of about 150 repeats. However, neocortex cells took much longer to reach this threshold—a process that happened so slowly that most of the cells never reached the toxic threshold. This finding could explain differences in disease severity across various parts of the brain.

"It's satisfying that a single mechanism could be at play in multiple brain areas, explaining pathologies that had once appeared to be so different," said Seva Kashin, co-first author on the paper and a scientist in the McCarroll lab.

The scientists also revealed that the HTT mutation caused different gene expression changes in cortical cells compared to those in the striatum—another possible explanation for Huntington's surprisingly variable effects in different parts of the brain.

The research team explored another curious, and controversial, observation. A small number of cells in the striatum and cortex of people with Huntington's disease have accumulations of huntingtin protein within the nuclei, known as nuclear inclusions. Scientists have long debated whether inclusions were dangerous, irrelevant or possibly even protective to cells.

This study suggests a new interpretation. Nuclear inclusions occurred in both striatal and cortical cells, but only in cells that had accumulated well over 150 HTT gene repeats and had not yet died—a finding that helps explain why these inclusions are so sparse. The inclusion-carrying human cells also exhibited extremely abnormal gene expression patterns, suggesting that the inclusions are a sign of the cell's final stage of life.

"Our findings suggest that nuclear inclusions may serve as a red flag that a neuron is undergoing severe molecular dysfunction and may be approaching cell death," said Won-Seok Lee, a co-first author on the paper and a postdoctoral researcher in the McCarroll lab.

Overall, the results suggest that Huntington's medicines being developed to slow or stop the repeat expansions could be beneficial not just in the striatum, but also in the neocortex and possibly other regions across the brain to address motor, cognitive or other symptoms that afflict patients.

"By pointing to a shared disease mechanism across brain regions, our findings suggest these new efforts are on the right track. We hope this evidence adds urgency to developing such treatments," said co-senior author Sabina Berretta, associate professor of psychiatry at Harvard Medical School and McLean Hospital.

"Above all, this work is a testament to the extraordinary generosity, commitment and foresight of brain donors and their families, whose contributions made these discoveries possible and to whom we are deeply grateful."

Publication details

Seva Kashin et al., Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons, Cell (2026). DOI: 10.1016/j.cell.2026.10.001

Journal information: Cell

Clinical categories

Neurology

Who's behind this story?

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Biological mechanism underlying Huntington's disease may be more widespread in the brain than previously thought (2026, October 28) retrieved 28 October 2026 from https://medicalxpress.com/news/2026-10-biological-mechanism-underlying-huntington-disease.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com